Andreas Maderna
30Patents
7h-index
70Co-inventors
72Inventor score
Filing activity: Jun 12, 2000 → Apr 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7759518B2 | Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK | Chemistry; Metallurgy | 32 | Active |
| US7820664B2 | Inhibitors of MEK | Chemistry; Metallurgy | 31 | Active |
| US8101799B2 | Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK | Chemistry; Metallurgy | 27 | Active |
| US8063049B2 | Inhibitors of MEK | Chemistry; Metallurgy | 24 | Active |
| US8828401B2 | Cytotoxic peptides and antibody drug conjugates thereof | Chemistry; Metallurgy | 8 | Active |
| US6664426B1 | Ether and ester derivatives of the perborate icosahedron | Chemistry; Metallurgy | 7 | Expired |
| US9249186B2 | Cytotoxic peptides and antibody drug conjugates thereof | Chemistry; Metallurgy | 7 | Active |
| US9138486B2 | Cytotoxic peptides and antibody drug conjugates thereof | Chemistry; Metallurgy | 6 | Active |
| US8513443B2 | Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-3,4-difluoro-2(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | Chemistry; Metallurgy | 3 | Active |
| US11744876B2 | Immunomodulator antibody drug conjugates and uses thereof | Human Necessities | 2 | Active |
| US7652047B2 | Phenylamino isothiazole carboxamidines as MEK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10086085B2 | Bifunctional cytotoxic agents | Chemistry; Metallurgy | 2 | Active |
| US7429667B2 | Phenylamino isothiazole carboxamidines as MEK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10662204B2 | Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents | Chemistry; Metallurgy | 1 | Active |
| US9873690B2 | 3-indol substituted derivatives, pharmaceutical compositions and methods for use | Chemistry; Metallurgy | 1 | Active |
| US8884058B2 | Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | Chemistry; Metallurgy | 1 | Active |
| US10590115B2 | Tetrahydroquinazoline derivatives useful as anticancer agents | Emerging Cross-Sectional Technologies | 1 | Active |
| US10538542B2 | Cyclopentane-based modulators of STING (stimulator of interferon genes) | Chemistry; Metallurgy | 1 | Active |
| US12144869B2 | Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates | Human Necessities | 0 | Active |
| US12337038B2 | Conjugates comprising cleavable beta-glucuronide-containing linkers | Chemistry; Metallurgy | 0 | Active |
| US9296686B2 | Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide | Chemistry; Metallurgy | 0 | Active |
| US10544095B2 | 3-indol substituted derivatives, pharmaceutical compositions and methods for use | Chemistry; Metallurgy | 0 | Active |
| US10391182B2 | Bifunctional cytotoxic agents | Chemistry; Metallurgy | 0 | Active |
| US10870706B2 | Bifunctional cytotoxic agents containing the CTI pharmacophore | Chemistry; Metallurgy | 0 | Active |
| US10968242B2 | Cyclopentane-based modulators of STING (stimulator of interferon genes) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.